1979
DOI: 10.1002/jps.2600680942
|View full text |Cite
|
Sign up to set email alerts
|

Nasal Absorption of Propranolol in Rats

Abstract: Keyphrases 0 Propranolol-nasal absorption, rats, compared to oral and intravenous dosage forms, bioavailability 0 P-Adrenergic blocking agents-propranolol, nasal absorption, compared to oral and intravenous dosage forms, rats, bioavailability 0 Dosage forms, nasal-propranolol, at)strrption, compared to oral and intravenous dosage forms, rats, bioavailability 4 5 ) S.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0

Year Published

1980
1980
2017
2017

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(12 citation statements)
references
References 4 publications
(1 reference statement)
0
12
0
Order By: Relevance
“…For example, the blood concentration of propranolol following nasal application is similar to that after intravenous application. 27) Propranolol is a highly permeable drug. A small volume of the drug solution applied nasally can reach the surface of nasal epithelium, but without being dissolved, whereas powder formulations, when administered nasally, directly reach the surface of the nasal epithelium and are dissolved in the small fluid volume.…”
Section: Discussionmentioning
confidence: 99%
“…For example, the blood concentration of propranolol following nasal application is similar to that after intravenous application. 27) Propranolol is a highly permeable drug. A small volume of the drug solution applied nasally can reach the surface of nasal epithelium, but without being dissolved, whereas powder formulations, when administered nasally, directly reach the surface of the nasal epithelium and are dissolved in the small fluid volume.…”
Section: Discussionmentioning
confidence: 99%
“…For example, propranolol, which is a highly permeable drug, shows a blood concentration profile following nasal application similar to that after intravenous administration [26]. In the case of nasal drug administration, a small volume of the drug solution (100 μL at most in humans) is applied.…”
Section: Discussionmentioning
confidence: 99%
“…Recently, diseases like anthrax and influenza are treated by using the nasal vaccines prepared by using the recombinant Bacillus anthracis protective antigen (rPA) and chitosan respectively 28 . The common diseases like measles, pertussis, meningitis and influenza are caused by the pathogens that mainly enter into the body through the nasal mucosal surfaces and hence are good candidates for nasal vaccines.…”
Section:  Delivery Of Drugs To Brain Through Nasal Cavitymentioning
confidence: 99%